Carisma Therapeutics Total Revenue

Carisma Therapeutics (CARM) currently reports a total revenue of $3.7M as of September 2025. That compares with $20M in the prior-year period — down 82.0% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Carisma Therapeutics's total revenue history and peer comparisons.

Carisma Therapeutics's total revenue decreased from $20M to $3.7M — a 82.0% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Carisma Therapeutics's total revenue of $3.7M is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Carisma Therapeutics reported $3.7M in total revenue as of September 2025. That compares with $20M in the prior-year period — down 82.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $3.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Carisma Therapeutics, and consider following CARM for alerts when major investors trade the stock.